Dow Up 1.13% Nasdaq Up 1.41%

Dynavax Technologies Corporation (DVAX)

-NasdaqCM
1.64 Down 0.05(2.96%) Oct 31, 3:59PM EDT
Prev Close:1.69
Open:1.72
Bid:N/A
Ask:1.81 x 2000
1y Target Est:4.50
Beta:4.03
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:1.64 - 1.74
52wk Range:1.10 - 2.14
Volume:4,384,765
Avg Vol (3m):1,746,200
Market Cap:431.12M
P/E (ttm):N/A
EPS (ttm):-0.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for DVAX

Comparison

Symbol% ChgMkt Cap
DVAXDown 2.96%431.12M
GSKUp 0.78%109.36B
MRKUp 1.10%167.14B
RHHBYDown 1.00%250.12B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):36.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.34
Quarterly EPS Est (Sep-14) :-0.09
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases, and cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback